From: Thymoquinone attenuates cisplatin-induced hepatotoxicity via nuclear factor kappa- β
Group 1 | Group 2 | Group 3 | |
---|---|---|---|
Initial body weight, g | 210 ± 10 | 203 ± 12 | 201 ± 12 |
Final body weight, g | 243 ± 18 | 172 ± 12a | 225 ± 12b |
ALT, U/L | 29.12 ± 1.12 | 98.32 ± 2.3a | 39.2 ± 1.3 |
AST, U/L | 26.78 ± 1.5 | 90.78 ± 1.14a | 48.5 ± 5.3 |
ALP, U/L | 167.34 ± 2.32 | 369.12 ± 18.8a | 215.3 ± 11.2b |
LDH, U/L | 75.67 ± 2.12 | 155.56 ± 2.4a | 112 ± 4.2b |
γGGT, U/L | 59.36 ± 1.45 | 109.5 ± 2.43a | 85 ± 3.5 |
t. protein, mg% | 9.53 ± 0.76 | 6.15 ± 1.27 | 6.8 ± 2.1 |
Albumin, mg% | 3.94 ± 0.98 | 2.4 ± 0.54a | 4.65 ± 2.5b |
t. Bilirubin, mg% | 0.75 ± 0.05 | 1.6 ± 0.23a | 1.1 ± 0.01b |